IDENTITY
CompoundGHK-Cu (Copper Tripeptide-1)
SubstanceGlycyl-L-Histidyl-L-Lysine Copper
Strength10 mg/ml
FormPeptide Injectable Solution
ClassPeptide / Research Compound
PEPTIDE PROFILE
StructureCopper-Bound Tripeptide
OriginNaturally occurring human peptide complex
Primary TargetCopper-dependent biological pathways
AdministrationSubcutaneous / Research Use
Biological RoleTissue Repair Signaling
PHARMACOLOGY
MechanismGrowth factor modulation
Copper ActivityCopper Ion Delivery
Collagen SupportEnhanced Fibroblast Activity
InflammationRegulatory Effects
Protein ClassBioactive Peptide
STORAGE & PACKAGE
BrandDragon Pharma
PackageVial
StorageRefrigerated 2-8°C
ProtectionProtect From Light
StabilityFollow Manufacturer Instructions
ADMINISTRATION PROFILE
Clinical ResearchExperimental Peptide Applications
Common Research Range100-200 mcg/day
AdministrationSubcutaneous Injection
FrequencyDaily Research Protocols
DurationVariable Research Periods
USAGE PROFILE
Primary InterestSkin & Tissue Research
Recovery FocusConnective Tissue Support
Collagen PathwayFibroblast Stimulation
Research AreaRegenerative Biology
Athletic InterestRecovery Research
RECOVERY PROFILE
Tissue SupportCollagen Formation Pathways
Skin BiologyExtracellular Matrix Support
Healing ResearchCellular Repair Signaling
Oxidative StressCopper-Dependent Enzymes
Recovery TypeRegenerative Support
COMPATIBILITY
Peptide ResearchCompatible With Peptide Studies
Growth ResearchInvestigated Alongside GH Pathways
Tissue StudiesConnective Tissue Research
CombinationRequires Scientific Evaluation
MonitoringLaboratory Assessment Recommended
MECHANISM OF ACTION
BindingCopper Peptide Interaction
FibroblastsSupports Cellular Activity
CollagenMatrix Formation Pathways
AngiogenesisResearch Association
Growth FactorsModulation of Signaling
PHARMACOKINETICS
Molecular TypeTripeptide Complex
AbsorptionPeptide Dependent
MetabolismPeptidase Breakdown
ClearanceBiological Degradation
DurationLimited Biological Exposure
SAFETY PROFILE
Clinical StatusResearch Compound
Injection RiskAseptic Technique Required
Immune ResponsePossible Peptide Sensitivity
Copper BalanceMonitor Biological Levels
Long-Term DataLimited Human Evidence
CONTRAINDICATIONS
Copper DisordersAvoid Without Medical Evaluation
PregnancyNot Established
AllergyPeptide Sensitivity Assessment
Liver FunctionConsider Monitoring
Medical ConditionsProfessional Assessment Required
CHEMICAL PROFILE
NameGHK-Cu Copper Peptide
FormulaC14H24CuN6O4
Molecular WeightApproximately 401.9 g/mol
CAS89030-95-5
ClassCopper Tripeptide
OVERVIEW
Dragon Pharma GHK-CU 10mg/ml contains the copper-binding tripeptide GHK-Cu, a naturally occurring peptide complex investigated for its role in connective tissue biology, extracellular matrix regulation, collagen-related pathways and cellular repair signaling. GHK-Cu has been studied in dermatological and regenerative research due to its interaction with copper-dependent enzymes and growth-related pathways.
BENEFITS
- Supports collagen-related pathways
- Investigated for connective tissue biology
- Supports extracellular matrix research
- Associated with skin regeneration studies
- May influence cellular repair signaling
- Participates in copper-dependent processes
- Non-hormonal peptide mechanism
POTENTIAL RISKS
- Limited long-term human research data
- Possible injection-site reactions
- Potential peptide sensitivity
- Requires sterile administration practices
- Copper metabolism considerations
- Unknown effects from non-approved use
- Product quality variability concerns
CONCLUSION
Dragon Pharma GHK-CU 10mg/ml is a copper peptide formulation containing GHK-Cu (Copper Tripeptide-1), a bioactive peptide studied for its involvement in extracellular matrix regulation, collagen pathways and tissue-repair signaling.
Unlike anabolic hormones, GHK-Cu does not function through androgen receptor activation or direct muscle protein synthesis stimulation. Its research interest is primarily connected to regenerative biology, skin science, connective tissue support and cellular communication mechanisms.
Scientific evidence continues to develop, and responsible evaluation requires consideration of product quality, biological response, laboratory monitoring and appropriate medical guidance.
Disclaimer
This content is provided exclusively for educational and informational purposes. It does not constitute medical advice, treatment recommendations or endorsement of non-approved peptide use. Readers should consult qualified healthcare professionals regarding medical questions and applicable regulations in their jurisdiction.
REFERENCES
GHK-Cu Copper Peptide Biological Research: PubMed
Copper Peptide Research Database: NCBI
Peptide Pharmacology Information: DrugBank
December 30, 2025
GHK-Cu 10 mg has been a quiet game-changer in my skincare. I used it topically for 10 weeks, morning and night. Around week four, my complexion looked brighter and more even. The peptide reduced dullness and improved hydration without making my skin oily. My wife even started using it after seeing my results. I’m now planning a second cycle after a short break. It’s subtle, but the difference in clarity and smoothness is undeniable.